Short communication · 14 Apr 2025
Conference abstractPublished 26 Jun 2017
Glycosides as scaffoldings for antibacterial pharmaceuticals
Queens College-City University of New York, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
With the increasing development of resistance by bacterial species to the action of classical antibiotics, there has developed a necessity for new approaches toward the control of bacterial regulation and treatment. Efforts of our laboratories have resulted in the generation of a series of surface modifications that result in the destruction of bacterial species of both Gram positive and Gram negative types rapidly and without the development of resistance to the action. These modified surfaces involve the incorporation of cationic lipids either covalently bound to the surface or embedded within the surface such that the cationic lipid portion protrudes and is able to interact with the bacteria. Our current efforts have been directed toward the development of material that could be used as treatments for bacterial infection and not simply the prevention of transmission of such pathogens. Glycosides, in several forms, have been demonstrated to be of particular value in the construction of such antibacterial agents. We herein report on several of these glycoside scaffoldings and their ability to hold cationic lipids useful for the treatment of bacterial diseases.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Glycobiology.
Commentary · 11 Apr 2025
The Essential Role of Glycosylation in Biological Processes and Disease Pathogenesis
Commentary · 10 Apr 2025
Exploring the Secrets of Glycomics: Decoding the Complexities of Sugars
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Glycobiology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Robert Engel”

